InnerScope Hearing Technologies (OTC: INND) Announces FDA Has Released The Final Rule For OTC Hearing Aids
InnerScope plans to register its hearing aid products, which include its HearingAssist and iHear branded hearing aid products, as OTC Hearing Aids in compliance with the FDA's Final Rule ("InnerScope's OTC Hearing Aid Products") and will be offered to its current and future Network of Wholesale Retailers to be sold in-store right off the shelf and online through each retailers' website.
- InnerScope plans to register its hearing aid products, which include its HearingAssist and iHear branded hearing aid products, as OTC Hearing Aids in compliance with the FDA's Final Rule ("InnerScope's OTC Hearing Aid Products") and will be offered to its current and future Network of Wholesale Retailers to be sold in-store right off the shelf and online through each retailers' website.
- The OTC Hearing Aids are expected to cost between $500 to $1,500 for a pair of hearing aids.
- InnerScope Hearing Technologies Inc. is a leading Direct-to-Consumer (DTC) manufacturer and distributor of FDA-registered hearing aids, hearing assistive devices, hearing health-related products, and Personal Sound Amplifier Products (PSAPs) ("Hearing Products") dedicated to addressing the global demand for affordable hearing solutions.
- For information related to InnerScope Hearing Technologies' latest hearing aids and related hearing products, please visit: